| NJ3 | Name: | 2-chloranyl-1-[3-[(2R,6S)-4-[(4-chlorophenyl)amino]-2,6-dimethyl-oxan-4-yl]carbonyl-3,9-diazaspiro[5.5]undecan-9-yl]ethanone | Formula: | C25 H35 Cl2 N3 O3 | SMILES: | C[CH]1CC(C[CH](C)O1)(Nc2ccc(Cl)cc2)C(=O)N3CCC4(CCN(CC4)C(=O)CCl)CC3 | InChi: | InChI=1S/C25H35Cl2N3O3/c1-18-15-25(16-19(2)33-18,28-21-5-3-20(27)4-6-21)23(32)30-13-9-24(10-14-30)7-11-29(12-8-24)22(31)17-26/h3-6,18-19,28H,7-17H2,1-2H3/t18-,19+,25+ | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 2-chloranyl-1-[3-[(2~{R},6~{S})-4-[(4-chlorophenyl)amino]-2,6-dimethyl-oxan-4-yl]carbonyl-3,9-diazaspiro[5.5]undecan-9-yl]ethanone |
|
| NJC | Name: | (2S,6R)-N-[[7-(2-chloranylethanoyl)-7-azaspiro[3.5]nonan-2-yl]methyl]-4-[(4-chlorophenyl)amino]-2,6-dimethyl-oxane-4-carboxamide | Formula: | C25 H35 Cl2 N3 O3 | SMILES: | C[CH]1CC(C[CH](C)O1)(Nc2ccc(Cl)cc2)C(=O)NCC3CC4(CCN(CC4)C(=O)CCl)C3 | InChi: | InChI=1S/C25H35Cl2N3O3/c1-17-11-25(12-18(2)33-17,29-21-5-3-20(27)4-6-21)23(32)28-16-19-13-24(14-19)7-9-30(10-8-24)22(31)15-26/h3-6,17-19,29H,7-16H2,1-2H3,(H,28,32)/t17-,18+,25+ | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | (2~{S},6~{R})-~{N}-[[7-(2-chloranylethanoyl)-7-azaspiro[3.5]nonan-2-yl]methyl]-4-[(4-chlorophenyl)amino]-2,6-dimethyl-oxane-4-carboxamide |
|
| NJI | Name: | 2-chloranyl-1-[7-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-2-yl]ethanone | Formula: | C21 H27 Cl2 N3 O3 | SMILES: | ClCC(=O)N1CC2(CCN(CC2)C(=O)C3(CCOCC3)Nc4ccc(Cl)cc4)C1 | InChi: | InChI=1S/C21H27Cl2N3O3/c22-13-18(27)26-14-20(15-26)5-9-25(10-6-20)19(28)21(7-11-29-12-8-21)24-17-3-1-16(23)2-4-17/h1-4,24H,5-15H2 | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 2-chloranyl-1-[7-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-2-yl]ethanone |
|
| NJR | Name: | 2-chloranyl-N-[[1-[2-[(4-chlorophenyl)amino]-2-methyl-propanoyl]piperidin-4-yl]methyl]ethanamide | Formula: | C18 H25 Cl2 N3 O2 | SMILES: | CC(C)(Nc1ccc(Cl)cc1)C(=O)N2CCC(CC2)CNC(=O)CCl | InChi: | InChI=1S/C18H25Cl2N3O2/c1-18(2,22-15-5-3-14(20)4-6-15)17(25)23-9-7-13(8-10-23)12-21-16(24)11-19/h3-6,13,22H,7-12H2,1-2H3,(H,21,24) | Synonyms: | prop-2-en-1-yl 7-O-carbamoyl-L-glycero-alpha-D-manno-heptoside | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 2-chloranyl-~{N}-[[1-[2-[(4-chlorophenyl)amino]-2-methyl-propanoyl]piperidin-4-yl]methyl]ethanamide |
|
| 9O2 | Name: | ~{N}-[3-[7-azanyl-4-(2-phenylethylamino)quinazolin-2-yl]phenyl]propanamide | Formula: | C25 H25 N5 O | SMILES: | CCC(=O)Nc1cccc(c1)c2nc(NCCc3ccccc3)c4ccc(N)cc4n2 | InChi: | InChI=1S/C25H25N5O/c1-2-23(31)28-20-10-6-9-18(15-20)24-29-22-16-19(26)11-12-21(22)25(30-24)27-14-13-17-7-4-3-5-8-17/h3-12,15-16H,2,13-14,26H2,1H3,(H,28,31)(H,27,29,30) | Definition date: | 2017-06-15 | Last modified: | 2024-09-27 | Release date: | 2017-09-06 | Identifier: | ~{N}-[3-[7-azanyl-4-(2-phenylethylamino)quinazolin-2-yl]phenyl]propanamide |
|
| NK | Name: | SALICYLALDEHYDE | Formula: | C7 H6 O2 | SMILES: | O=Cc1ccccc1O | InChi: | InChI=1S/C7H6O2/c8-5-6-3-1-2-4-7(6)9/h1-5,9H | Definition date: | 2005-11-14 | Last modified: | 2024-09-27 | Identifier: | 2-hydroxybenzaldehyde |
|
| 9O5 | Name: | 4-[3-[7-azanyl-4-(2-phenylethylamino)quinazolin-2-yl]phenyl]butan-2-one | Formula: | C26 H26 N4 O | SMILES: | CC(=O)CCc1cccc(c1)c2nc(NCCc3ccccc3)c4ccc(N)cc4n2 | InChi: | InChI=1S/C26H26N4O/c1-18(31)10-11-20-8-5-9-21(16-20)25-29-24-17-22(27)12-13-23(24)26(30-25)28-15-14-19-6-3-2-4-7-19/h2-9,12-13,16-17H,10-11,14-15,27H2,1H3,(H,28,29,30) | Definition date: | 2017-06-15 | Last modified: | 2024-09-27 | Release date: | 2017-09-06 | Identifier: | 4-[3-[7-azanyl-4-(2-phenylethylamino)quinazolin-2-yl]phenyl]butan-2-one |
|
| NK6 | Name: | N-[[1-[4-azanyl-1-[(4-chlorophenyl)amino]cyclohexyl]carbonylpiperidin-4-yl]methyl]-2-chloranyl-ethanamide | Formula: | C21 H30 Cl2 N4 O2 | SMILES: | N[CH]1CC[C](CC1)(Nc2ccc(Cl)cc2)C(=O)N3CC[CH](CC3)CNC(=O)CCl | InChi: | InChI=1S/C21H30Cl2N4O2/c22-13-19(28)25-14-15-7-11-27(12-8-15)20(29)21(9-5-17(24)6-10-21)26-18-3-1-16(23)2-4-18/h1-4,15,17,26H,5-14,24H2,(H,25,28)/t17-,21- | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | ~{N}-[[1-[4-azanyl-1-[(4-chlorophenyl)amino]cyclohexyl]carbonylpiperidin-4-yl]methyl]-2-chloranyl-ethanamide |
|
| NKK | Name: | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide | Formula: | C29 H44 N8 O4 | SMILES: | O=CC(NC(=O)C(NC(=O)C(NC(=O)c2ccc1c(cccc1)c2)CCCCN)CCCCN)CCCNC(=[N@H])N | InChi: | InChI=1S/C29H44N8O4/c30-15-5-3-11-24(27(40)35-23(19-38)10-7-17-34-29(32)33)37-28(41)25(12-4-6-16-31)36-26(39)22-14-13-20-8-1-2-9-21(20)18-22/h1-2,8-9,13-14,18-19,23-25H,3-7,10-12,15-17,30-31H2,(H,35,40)(H,36,39)(H,37,41)(H4,32,33,34)/t23-,24-,25-/m0/s1 | Definition date: | 2008-08-22 | Last modified: | 2024-09-27 | Identifier: | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide |
|
| NKL | Name: | 2-chloranyl-1-[2-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | Formula: | C21 H27 Cl2 N3 O3 | SMILES: | ClCC(=O)N1CCC2(CC1)CN(C2)C(=O)C3(CCOCC3)Nc4ccc(Cl)cc4 | InChi: | InChI=1S/C21H27Cl2N3O3/c22-13-18(27)25-9-5-20(6-10-25)14-26(15-20)19(28)21(7-11-29-12-8-21)24-17-3-1-16(23)2-4-17/h1-4,24H,5-15H2 | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 2-chloranyl-1-[2-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-7-yl]ethanone |
|
| 9OW | Name: | 3-selanyl-L-alaninamide | Formula: | C3 H8 N2 O Se | SMILES: | NC(=O)C(N)C[SeH] | InChi: | InChI=1S/C3H8N2OSe/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H2,5,6)/t2-/m0/s1 | Definition date: | 2021-10-21 | Last modified: | 2024-09-27 | Release date: | 2022-03-16 | Identifier: | 3-selanyl-L-alaninamide |
|
| NL7 | Name: | 4-[(5-methoxypyridin-3-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C12 H12 N2 O6 S2 | SMILES: | c1cc(S(=O)(=O)O)ccc1S(Nc2cc(OC)cnc2)(=O)=O | InChi: | InChI=1S/C12H12N2O6S2/c1-20-10-6-9(7-13-8-10)14-21(15,16)11-2-4-12(5-3-11)22(17,18)19/h2-8,14H,1H3,(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(5-methoxypyridin-3-yl)sulfamoyl]benzene-1-sulfonic acid |
|
| NL9 | Name: | [1-(3-chlorophenyl)-1H-pyrazol-4-yl]boronic acid | Formula: | C9 H8 B Cl N2 O2 | SMILES: | Clc1cccc(c1)n2ncc(c2)B(O)O | InChi: | InChI=1S/C9H8BClN2O2/c11-8-2-1-3-9(4-8)13-6-7(5-12-13)10(14)15/h1-6,14-15H | Definition date: | 2013-08-06 | Last modified: | 2024-09-27 | Release date: | 2014-07-30 | Identifier: | [1-(3-chlorophenyl)-1H-pyrazol-4-yl]boronic acid |
|
| NLB | Name: | 6-(benzyloxy)-L-norleucine | Formula: | C13 H19 N O3 | SMILES: | O=C(O)C(N)CCCCOCc1ccccc1 | InChi: | InChI=1S/C13H19NO3/c14-12(13(15)16)8-4-5-9-17-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,14H2,(H,15,16)/t12-/m0/s1 | Definition date: | 2014-11-09 | Last modified: | 2024-09-27 | Release date: | 2015-02-11 | Identifier: | 6-(benzyloxy)-L-norleucine |
|
| NLF | Name: | N-formyl-L-tryptophan | Formula: | C12 H12 N2 O3 | SMILES: | O=C(O)C(NC=O)Cc1c[NH]c2ccccc21 | InChi: | InChI=1S/C12H12N2O3/c15-7-14-11(12(16)17)5-8-6-13-10-4-2-1-3-9(8)10/h1-4,6-7,11,13H,5H2,(H,14,15)(H,16,17)/t11-/m0/s1 | Definition date: | 2022-04-05 | Last modified: | 2024-09-27 | Release date: | 2022-08-17 | Identifier: | N-formyl-L-tryptophan |
|
| NLJ | Name: | 4-[(2-methoxypyridin-3-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C12 H12 N2 O6 S2 | SMILES: | c1(ccc(cc1)S(=O)(=O)O)S(Nc2c(nccc2)OC)(=O)=O | InChi: | InChI=1S/C12H12N2O6S2/c1-20-12-11(3-2-8-13-12)14-21(15,16)9-4-6-10(7-5-9)22(17,18)19/h2-8,14H,1H3,(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(2-methoxypyridin-3-yl)sulfamoyl]benzene-1-sulfonic acid |
|
| 9PR | Name: | N-methyl-L-prolinamide | Formula: | C6 H12 N2 O | SMILES: | O=C(NC)C1NCCC1 | InChi: | InChI=1S/C6H12N2O/c1-7-6(9)5-3-2-4-8-5/h5,8H,2-4H2,1H3,(H,7,9)/t5-/m0/s1 | Definition date: | 2010-12-09 | Last modified: | 2024-09-27 | Identifier: | N-methyl-L-prolinamide |
|
| NLM | Name: | 4-[(3-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C11 H9 Cl N2 O5 S2 | SMILES: | N(S(c1ccc(cc1)S(=O)(=O)O)(=O)=O)c2ncccc2Cl | InChi: | InChI=1S/C11H9ClN2O5S2/c12-10-2-1-7-13-11(10)14-20(15,16)8-3-5-9(6-4-8)21(17,18)19/h1-7H,(H,13,14)(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(3-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid |
|
| NLS | Name: | 4-[(6-fluoropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C11 H9 F N2 O5 S2 | SMILES: | N(c1nc(F)ccc1)S(c2ccc(S(=O)(=O)O)cc2)(=O)=O | InChi: | InChI=1S/C11H9FN2O5S2/c12-10-2-1-3-11(13-10)14-20(15,16)8-4-6-9(7-5-8)21(17,18)19/h1-7H,(H,13,14)(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(6-fluoropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid |
|
| NLV | Name: | 4-[(6-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C11 H9 Cl N2 O5 S2 | SMILES: | N(c1nc(Cl)ccc1)S(c2ccc(cc2)S(=O)(=O)O)(=O)=O | InChi: | InChI=1S/C11H9ClN2O5S2/c12-10-2-1-3-11(13-10)14-20(15,16)8-4-6-9(7-5-8)21(17,18)19/h1-7H,(H,13,14)(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(6-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid |
|
| NLW | Name: | L-leucinamide | Formula: | C6 H14 N2 O | SMILES: | CC(CC(C(N)=O)N)C | InChi: | InChI=1S/C6H14N2O/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H2,8,9)/t5-/m0/s1 | Definition date: | 2016-03-22 | Last modified: | 2024-09-27 | Release date: | 2016-08-03 | Identifier: | L-leucinamide |
|
| NLY | Name: | N-(4-aminobutyl)glycine | Formula: | C6 H14 N2 O2 | SMILES: | O=C(O)CNCCCCN | InChi: | InChI=1S/C6H14N2O2/c7-3-1-2-4-8-5-6(9)10/h8H,1-5,7H2,(H,9,10) | Definition date: | 2012-10-18 | Last modified: | 2024-09-27 | Release date: | 2013-10-09 | Identifier: | N-(4-aminobutyl)glycine |
|
| 9QJ | Name: | (1S,3S,4E)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic acid | Formula: | C14 H19 N2 O7 P | SMILES: | C(c1c(O)c(C)ncc1COP(O)(O)=O)C2C(=N)CC(C2)C(O)=O | InChi: | InChI=1S/C14H19N2O7P/c1-7-13(17)11(10(5-16-7)6-23-24(20,21)22)3-8-2-9(14(18)19)4-12(8)15/h5,8-9,15,17H,2-4,6H2,1H3,(H,18,19)(H2,20,21,22)/b15-12+/t8-,9-/m0/s1 | Definition date: | 2017-05-26 | Last modified: | 2024-09-27 | Release date: | 2017-08-30 | Identifier: | (1S,3S,4E)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic acid |
|
| NME | Name: | METHYLAMINE | Formula: | C H5 N | SMILES: | NC | InChi: | InChI=1S/CH5N/c1-2/h2H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | methanamine |
|
| NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|